Eliza Hall

Type: Person
Name: Eliza Hall
First reported Oct 04 2014 - Updated Oct 04 2014 - 1 reports

Once upon a time there was a floating triplex

Once upon a time, inconvenient Sydney houses could be shifted sideways. Literally.It was 1941 when an art moderne Potts Point waterfront residence atop a boat shed was barged across the harbour to Neutral Bay.The eccentric owner, William Crowle, dismantled ... [Published Cowra Guardian - Oct 04 2014]
First reported Sep 30 2014 - Updated Oct 01 2014 - 1 reports

New bowel cancer weapon

A PROMISING breakthrough by Melbourne medical researchers reveals that more than 80 per cent of bowel cancers could be treated with existing drugs. The Walter and Eliza Hall team found that a specific class of drugs not only stops tumours growing in pre-clinical ... [Published NEWS.com.au - Sep 30 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Séralini study is given new life, but where's the new data?

By David Vaux , Walter and Eliza Hall InstituteA controversial 2012 paper on the effects of genetically modified (GM) maize and the herbicide glyphosate on tumour growth in rats – a paper later retracted by the journal – has been republished , with ... [Published GMO Pundit a.k.a. David Tribe - Jun 25 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Alchemia Announces First Patient Enrolled in Investigator-Led Phase II Trial of HA-Irinotecan and Erbitux ("CHIME" Trial)

BRISBANE, AUSTRALIA--(Marketwired - Jun 20, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that the first patient has been enrolled into the new clinical trial of HA-Irinotecan and Erbitux® (cetuximab); ... [Published Marketwire - Breaking News Releases - Jun 20 2014]

More Content

All (5) | News (3) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Once upon a time there was a floating triplex [Published Cowra Guardian - Oct 04 2014]
New bowel cancer weapon [Published NEWS.com.au - Sep 30 2014]
Séralini study is given new life, but where's t... [Published GMO Pundit a.k.a. David Tribe - Jun 25 2014]
Alchemia Announces First Patient Enrolled in In... [Published Marketwire - Breaking News Releases - Jun 20 2014]
Dr. Bruce Stillman CSHL President wins 2014 Her... [Published BioPortfolio - Apr 21 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Séralini study is given new life, but where's t... [Published GMO Pundit a.k.a. David Tribe - Jun 25 2014]
By David Vaux , Walter and Eliza Hall InstituteA controversial 2012 paper on the effects of genetically modified (GM) maize and the herbicide glyphosate on tumour growth in rats – a paper later retracted by the journal – has been republished , with ...
Alchemia Announces First Patient Enrolled in In... [Published Marketwire - Breaking News Releases - Jun 20 2014]
BRISBANE, AUSTRALIA--(Marketwired - Jun 20, 2014) - Alchemia Limited (ASX: ACL), a drug discovery and development company, today announced that the first patient has been enrolled into the new clinical trial of HA-Irinotecan and Erbitux® (cetuximab); ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.